Drugs – Page 27 – Healthy Skeptic

Jul 30 2010

New York Times

By Kevin Roche Headlines No Comments

In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market.

Jul 28 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Aetna Inc. is contracting out long-term administration of its pharmacy-benefit business to CVS Caremark Corp., in a 12-year agreement that could offer prescription-drug discounts to some 10 million members

Jul 27 2010

FiscalTimes

By Kevin Roche Headlines No Comments

Cash-strapped state officials might want to take a second look at how the 45 million people who receive health care through Medicaid purchase prescription drugs

Jul 26 2010

American Enterprise Institute

By Kevin Roche Research No Comments

American Enterprise Institute: Overspending on Multi-Source Drugs in Medicaid

Jul 26 2010

Fiscal Times

By Kevin Roche Headlines No Comments

A new study from the American Enterprise Institute suggests many patients are still using pricey brand-name drugs long after comparable generics become available.

Jul 24 2010

2010 Potpourri XXVI

By Kevin Roche Commentary No Comments

More midsummer musings, covering possible replacements for AWP, the effect of Part D on heart failure drug use, the VA's telehealth programs, venture capital activity, self-management of high blood pressure,…

Read More

Jul 21 2010

The Effect of Price Regulation on New Drug Development

By Kevin Roche Commentary No Comments

For several decades drug companies have taken a beating over their pricing and many governments have limited how those companies charge for their products. A new study suggests that such…

Read More

Jul 17 2010

2010 Potpourri XXV

By Kevin Roche Commentary No Comments

Another week, another potpourri, this time with items on workers' compensation drug spending, benefit consulting firm mergers, hospital readmissions, geographic variation in spending and use of mobile vans to deliver…

Read More

Jul 14 2010

Washington Post

By Kevin Roche Headlines No Comments

Pharmaceutical group shifts tone with new pick for president

Jul 13 2010

Fiscal Times

By Kevin Roche Headlines No Comments

There will be more at stake than just one drug’s future when the Food and Drug Administration opens a two-day hearing Tuesday on the safety of the diabetes drug Avandia.

Jul 13 2010

New York Times

By Kevin Roche Headlines No Comments

Not only was Avandia no better than Actos, but the study also provided clear signs that it was riskier to the heart. But instead of publishing the results, the company spent the next 11 years trying to cover them up

Jul 12 2010

New York Times

By Kevin Roche Headlines No Comments

Merck plans to lay off about 15 percent of its work force — about 15,000 people — over the next two years as part of a global merger restructuring

Jul 09 2010

Boston Globe

By Kevin Roche Headlines No Comments

When blockbuster drugs lose their patent protection, state Medicaid programs can save millions by switching to generics. A new study shows some states switch more quickly than others

Jun 28 2010

Medicare and Home Infusion

By Kevin Roche Commentary No Comments

Home infusion of therapeutic agents is increasing, especially as more biologics, which tend to need infusion, are approved for use. GAO looked at how Medicare FFS handles home infusion versus…

Read More

Jun 26 2010

2010 Potpourri XXIII

By Kevin Roche Commentary No Comments

Once more into the breach with the Saturday health care roundup, including medication adherence, monitoring patients' health status in their homes, Massachusetts' reform update and insurance costs, hospitals' economic contribution,…

Read More

© 2025 Healthy Skeptic.